Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Vermont Rx Marketing Price Disclosure Law Exempts “Non-Pill” Products

Executive Summary

A recently enacted Vermont law requiring disclosure of the average wholesale price for pharmaceutical products excludes "non-pill" formulations

You may also be interested in...



Lipitor, Lovastatin Are “Best Buy” Statins, Consumers Union Says

Pfizer's Lipitor and generic lovastatin are rated "best buy" in the statin class of cholesterol lowering drugs by Consumer Reports publisher Consumers Union

Rx Price Comparison Site Launches With 20 Cards; HHS Urges Patience

The Medicare website has drug pricing data available from about half of the approved drug discount cards

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS045384

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel